Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
10/2009
10/13/2009CA2222513C Agents binding specifically to biotin for detecting damaged nucleic acid bases
10/13/2009CA2217485C Controlled release biodegradable nanoparticles containing insulin
10/13/2009CA2215933C Producing immunogenic constructs using soluble carbohydrates activated via organic cyanylating reagents
10/13/2009CA2110291C Methods and compositions based on inhibition of cell invasion and fibrosis by anionic polymers
10/13/2009CA2103583C Recombinant transferrins, transferrin half-molecules and mutants thereof
10/13/2009CA2092271C Use of g-csf for treating taxol side-effects
10/08/2009WO2009124178A1 Method for prophylaxis or treatment of feline infectious peritonitis
10/08/2009WO2009124056A2 Alpha-fetoprotein for treating disease
10/08/2009WO2009124055A1 Human apoa-i mutants
10/08/2009WO2009124046A1 Suture line administration technique using botulinum toxins
10/08/2009WO2009123978A1 Methods of diagnosing, preventing and treating bone mass diseases
10/08/2009WO2009123903A1 Hemostatic microspheres
10/08/2009WO2009123761A1 Beta-turn peptidomimetic cyclic compounds for treating dry eye
10/08/2009WO2009123759A2 Therapeutic uses of biocompatible biogel compositions
10/08/2009WO2009123573A1 Anticoagulants derived from naja nigricollis snake venom
10/08/2009WO2009123481A1 Compositions and methods for treatment of neoplastic disease
10/08/2009WO2009123457A2 Compositions and methods for treating sweet itch
10/08/2009WO2009123454A1 Compositions and method for reducing scar formation in wound healing
10/08/2009WO2009123188A1 Partial peptide of survivin presented on mhc class ii molecule and use thereof
10/08/2009WO2009123174A1 Preparation of type a2 botulinum neurotoxin
10/08/2009WO2009123162A1 Method for determination of edema associated with liver disease
10/08/2009WO2009122748A1 Therapeutic agent for respiratory diseases or allergic diseases
10/08/2009WO2009122719A1 Substance and composition both capable of imparting heat resistance
10/08/2009WO2009122288A2 Liquid and freeze dried formulations
10/08/2009WO2009122227A2 Treating cerebrovascular diseases with erythropoietin and granulocyte-colony stimulating factor jointly
10/08/2009WO2009121828A1 Use of defensins against meningitis
10/08/2009WO2009121566A1 Mzb1, a novel b cell factor, and uses thereof
10/08/2009WO2009121483A1 Highly bridged peptides from actinomadura namibiensis
10/08/2009WO2009121223A2 Use of prourokinase and variants thereof in facilitated percutaneous coronary intervention in patients with acute myocardial infarction
10/08/2009WO2009121210A1 Double-stranded polyethylene glycol modified growth hormone, preparation method and application thereof
10/08/2009WO2009121183A1 Dispersinbtm, 5-fluorouracil, deoxyribonuclease i and proteinase k-based antibiofilm compositions and uses thereof
10/08/2009WO2009121176A1 Insulin-induced gene (insig) peptide compositions and methods for cytoprotection
10/08/2009WO2009102715A3 Peptide therapy for ocular herpes infections
10/08/2009WO2009102488A3 A humanized model of membrane attack complex (mac) formation on murine retina and compositions, kits and methods for treatment of macular degeneration
10/08/2009WO2009102467A3 Devices, formulations, and methods for delivery of multiple beneficial agents
10/08/2009WO2009094456A3 Use of high-dose, post-transplantation oxazaphosphorine drugs for reduction of transplant rejection
10/08/2009WO2009092891A3 Modification of intrinsically disordered sequences for preparing vaccines
10/08/2009WO2009088264A3 A composition containing arazyme for the prevention and treatment of arthritis
10/08/2009WO2009040045A3 Use of tyr-w-mif-1 and urocortin 2 as therapeutic agents
10/08/2009WO2009033788A3 Use of a jck-301, optionally in combination with big endothelin, as a therapeutic agent.
10/08/2009WO2009033758A3 Use of the peptide phpfhffvyk as therapeutic agent
10/08/2009WO2005009350A3 Fugetactic proteins, compositions and methods of use
10/08/2009US20090255004 G-Protein Coupled Receptor and Uses Therefor
10/08/2009US20090255003 Diagnostic and therapeutic target SLC39A11 proteins for neurodegenerative diseases
10/08/2009US20090253897 Structural protein of adeno-associated virus with modified antigenicity, its production and its use
10/08/2009US20090253864 IL-21 Derivatives and Variants
10/08/2009US20090253731 Method of identifying therapeutic agents
10/08/2009US20090253641 Methods for preventing or treating insulin resistance
10/08/2009US20090253640 Inhibitors of polyisoprenylated methylated protein methyl esterase
10/08/2009US20090253639 Opiorphin peptide derivatives as potent inhibitors of enkephalin-degrading ectopeptidases
10/08/2009US20090253638 Somatostatin Antagonists
10/08/2009US20090253637 Small peptides for the treatment of alzheimer's disease and other beta-amyloid protein disorders
10/08/2009US20090253636 Novel Antifungal Agent
10/08/2009US20090253635 Peptides and peptidomimetics having anti-proliferative activity and/or that augment nucleic acid damaging agents or treatments
10/08/2009US20090253634 Methods and Compositions for the Treatment of Gastrointestinal Disorders
10/08/2009US20090253633 Novel Combinations of DNAK Inhibitors With Known Antibacterial Agents
10/08/2009US20090253632 Therapeutic peptides and method
10/08/2009US20090253631 Anti-Inflammatory Peptides
10/08/2009US20090253630 Pegylated pth as pth receptor modulators and uses thereof
10/08/2009US20090253629 Use of defensins against meningitis
10/08/2009US20090253628 Use of PEGylated IGF-I variants for the treatment of neuromuscular disorders
10/08/2009US20090253627 Lactoferrin compositions and methods of wound treatment
10/08/2009US20090253626 50 Human Secreted Proteins
10/08/2009US20090253625 GLP-1, exendin-4, peptide analogs and uses thereof
10/08/2009US20090253624 Pharmacologically active antiviral peptides and methods of use
10/08/2009US20090253623 Gh secretagogues and uses thereof
10/08/2009US20090253622 Use of tlr3 agonists for the treatment of neurodegenerative disorders
10/08/2009US20090253621 Arabinogalactan protein having the property of absorbing fats and method for obtaining this arabinogalactan protein
10/08/2009US20090253620 Methods and compositions for treating gastrointestinal radiosensititivity in a subject
10/08/2009US20090253619 Novel peptide involved in energy homeostasis
10/08/2009US20090253618 Neuronal differentiation-inducing peptide and use thereof
10/08/2009US20090253617 Diagnosis and treatment of attentional disorders
10/08/2009US20090253616 Combination therapy for the treatment of cancer
10/08/2009US20090253615 No-modified hemoglobins and uses therefor
10/08/2009US20090253614 Oral insulin therapies & protocol
10/08/2009US20090253613 Solid-Fluid Composition
10/08/2009US20090253207 Gene delivery vectors provided with a tissue tropism for smooth muscle cells, and/or endothelial cells
10/08/2009US20090253175 Use to faciliate drug delivery of other drugs, or treat glycosaminoglycan associated pathologies, such as scarring, spinal cord injury, glaucoma, and cosmetic treatments
10/08/2009US20090253172 Growth factor homolog zvegf4
10/08/2009US20090253166 Conjugation of Peptides
10/08/2009US20090253125 Denaturat stable and/or protease resistant, chaperone-like oligomeric proteins, polynucleotides encoding same, their uses and methods of increasing a specific activity thereof
10/08/2009US20090252827 Horse feed and methods of treating horses
10/08/2009US20090252808 Controlled release of biological entities
10/08/2009US20090252798 Matrix-gel graft without cells
10/08/2009US20090252781 Hydrogel polymeric compositions and methods
10/08/2009US20090252778 Methods and devices for reducing tissue damage after ischemic injury
10/08/2009US20090252753 Immunomodulation for autoimmune type-2 diabetes
10/08/2009US20090252752 Kdr peptides and vaccines comprising the same
10/08/2009US20090252747 Immunization; used to elicit a humoral or cellular immune response
10/08/2009US20090252743 Antibody for use in the treatment of crohn's and inflammatory diseases such as ankylosing spondylitis; human tumor necrosis factor alpha (TNF) inhibitors
10/08/2009US20090252738 Compositions and methods of therapy for cancers characterized by expression of the tumor-associated antigen mn/ca ix
10/08/2009US20090252728 Nucleic acid and corresponding protein named 158p1d7 useful in the treatment and detection of bladder and other cancers
10/08/2009US20090252722 Botulinum Neurotoxin a Protein Receptor and Uses Thereof
10/08/2009US20090252720 Prolonged FIX Analogues and Derivatives
10/08/2009US20090252719 Use of fructanases in feed of hoofed animals, preferably to prevent diseases
10/08/2009US20090252718 Phospholipase(s) and Use(s) Thereof
10/08/2009US20090252717 Compositions and Methods for Treating Polyglutamine-Expansion Neurodegenerative Diseases
10/08/2009US20090252714 Autoantigenes for Improved Diagnosis, Prognosis and Treatment of Inflammatory Neurological Diseases
10/08/2009US20090252712 Chimeric c3-like rho antagonist bone therapeutic
10/08/2009US20090252706 Tetrahydropyridothiophenes As Antripoliferative Agents For The Treatment Of Cancer
1 ... 722 723 724 725 726 727 728 729 730 731 732 733 734 735 736 737 738 739 740 741 742 ... 3163